PRESSR: University of Sharjah and Haleon join forces to upskill UAE healthcare professionals

Sharjah, United Arab Emirates: Haleon, a leader in consumer healthcare, has entered a strategic partnership with the University of Sharjah to empower the next generation of healthcare professionals and advance a more resilient, inclusive healthcare ecosystem across the UAE.

This collaboration introduces an academic program designed to train young professionals in self-care, community health advocacy, and preventative health.

As part of the agreement, Haleon will co-host a series of conferences, workshops, and seminars with the University of Sharjah, offering students and recent graduates direct access to industry expertise and emerging trends. Haleon will also participate in the University’s career fairs, providing mentorship and career guidance to aspiring professionals navigating the evolving healthcare landscape.

In addition, Haleon leadership will deliver specialised sessions aligned with the University’s curriculum, bridging the gap between theory and practice and empowering students to apply their academic knowledge to real-world challenges.

“We believe that supporting future healthcare leaders begins with education and collaboration. By joining forces with institutions like the University of Sharjah, we’re equipping students with not just the knowledge, but also the confidence and perspective to shape healthier communities. It’s through partnerships like this that we bring our purpose to life – advancing healthcare with science, access and opportunity. Moreover, this collaboration reinforces our commitment to advancing healthcare education in the UAE and beyond, as well as shaping a globally competitive workforce capable of driving innovation in this sector,” said Arda Arat, General Manager, Haleon, Gulf & Near East.

Mohammed Elgamal, Dean, University of Sharjah, added: “This partnership with Haleon marks a significant milestone in our ongoing efforts to bridge the gap between academia and industry. By integrating real-world learning into our curriculum, we are equipping our students and graduates with the practical skills, critical insights, and professional confidence needed to thrive as future-ready healthcare leaders.”

Healthcare education remains a strategic priority for Haleon. The company continues to invest in digital health literacy, mental wellbeing, and community health initiatives. Earlier this year, Haleon launched the Health Inclusivity Index for the region, in collaboration with Economist Impact. The index is a comprehensive benchmarking tool that evaluates 40 countries across 58 indicators of health literacy, outreach, inclusion, and equity. The UAE ranked among the top performers, underscoring its global leadership in inclusive and preventative care.

Highlighting its commitment to innovation, Haleon also introduced the Pain Management Institute, a dedicated platform for advancing education and best practices in effective pain management.

About Haleon:

Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon’s product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, Parodontax and Centrum - are built on trusted science, innovation and deep human understanding.

For more information, please visit www.haleon.com

Media Contacts:

Disha Dadlani: ddadlani@apcoworldwide.com

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.